Autologous stem cell transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloidosis: Results of the French multicentric randomized trial (MAG and IFM intergroup).

被引：0
|
作者：
Jaccard, A
Moreau, P
Leblond, V
Leleu, X
Benboubker, L
Hermine, O
Recher, C
Malphette, M
Lioure, B
Royer, B
Grosbois, B
Jaubert, J
Preux, PM
Cogne, M
Fermand, JP
机构：
[1] CHU Limoges, Limoges, France
[2] CHU Nantes, F-44035 Nantes 01, France
[3] CHU Lille, F-59037 Lille, France
[4] CHU Tours, Tours, France
[5] CHU Toulouse, Toulouse, France
[6] Pitie & Necker, Paris, France
[7] CHU Strasbourg, F-67000 Strasbourg, France
[8] CHU Amiens, Amiens, France
[9] CHU St Etienne, St Etienne, France
[10] CHU Rennes, Rennes, France
[11] Hop St Louis, Paris, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
421
引用
收藏
页码：127A / 127A
页数：1
相关论文
共 50 条
  • [21] Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
    Palladini, G
    Perfetti, V
    Obici, L
    Caccialanza, R
    Semino, A
    Adami, F
    Cavallero, G
    Rustichelli, R
    Virga, G
    Merlini, G
    BLOOD, 2004, 103 (08) : 2936 - 2938
  • [22] High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement
    Girnius, Saulius
    Seldin, David C.
    Quillen, Karen
    Andrea, Nancy T.
    Sloan, John Mark
    Berk, John L.
    Ruberg, Frederick L.
    Meier-Ewert, Hans
    Sanchorawala, Vaishali
    BLOOD, 2011, 118 (21) : 896 - 896
  • [23] High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: Results of a prospective randomized trial.
    Sanchorawala, V
    Wright, DG
    Seldin, DC
    Falk, RH
    Finn, KT
    Dember, LM
    Berk, J
    Quillen, K
    Wright, EC
    Comenzo, RL
    Skinner, M
    BLOOD, 2001, 98 (11) : 815A - 816A
  • [24] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    J B Perz
    A Rahemtulla
    C Giles
    R M Szydlo
    J Davis
    D Gopaul
    J Gillmore
    C J Mathias
    P N Hawkins
    J F Apperley
    Bone Marrow Transplantation, 2006, 37 : 937 - 943
  • [25] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    Perz, JB
    Rahemtulla, A
    Giles, C
    Szydlo, RM
    Davis, J
    Gopaul, D
    Gillmore, J
    Mathias, CJ
    Hawkins, PN
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 937 - 943
  • [26] Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis
    Hoshino, Junichi
    Ubara, Yoshifumi
    Ohashi, Kenichi
    Takemoto, Fumi
    Takaichi, Kenmei
    CLINICAL KIDNEY JOURNAL, 2008, 1 (06): : 414 - 416
  • [27] High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study
    Skinner, M
    Sanchorawala, V
    Seldin, DC
    Dember, LM
    Falk, RH
    Berk, JL
    Anderson, JJ
    O'Hara, C
    Finn, KT
    Libbey, CA
    Wiesman, J
    Quillen, K
    Swan, N
    Wright, DG
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 85 - 93
  • [28] Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65
    Seldin, David C.
    Anderson, Jennifer J.
    Skinner, Martha
    Malek, Karim
    Wright, Daniel G.
    Quillen, Karen
    Finn, Kathleen
    Oran, Betul
    Sanchorawala, Vaishali
    BLOOD, 2006, 108 (12) : 3945 - 3947
  • [29] An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis
    Sanchorawala, Vaishali
    Seldin, David C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (04): : 261 - 269
  • [30] Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
    Teresa Cibeira, Maria
    Sanchorawala, Vaishali
    Seldin, David C.
    Quillen, Karen
    Berk, John L.
    Dember, Laura M.
    Segal, Adam
    Ruberg, Frederick
    Meier-Ewert, Hans
    Andrea, Nancy T.
    Sloan, J. Mark
    Finn, Kathleen T.
    Doros, Gheorghe
    Blade, Joan
    Skinner, Martha
    BLOOD, 2011, 118 (16) : 4346 - 4352
12345